We are an advanced manufacturing company solving the greatest challenges in drug delivery for novel therapeutics. Today, millions of patients face the burden of frequent hospital visits, enduring painful, costly, and time-consuming intravenous injections to receive their life-saving medications. AcousticaBio transforms this process, making drug delivery as simple as receiving a routine flu shot.
Utilizing advanced microparticle technology and our Harvard-patented acoustophoretic platform, we convert intravenously delivered biologic products into highly concentrated, small-volume subcutaneous injections - all without the use of solvents or cumbersome post-processing. Our versatile technology extends beyond monoclonal antibodies, offering an unparalleled ability to formulate a wide range of materials across multiple therapeutic areas.
We are committed to collaborating with biopharmaceutical partners to advance their products, improve the quality of care, and enable patients to self-administer their life-saving medications from the comfort of their homes. Join us at AcousticaBio, where we value how work gets done just as much as what ultimately gets accomplished.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 277 Broadway,
- Industry
- Biotechnology
- Website
- http://www.acoustica.bio
- Keywords
- in cell & gene therapy.
- HQ
- Cambridge, MA
Acousticabio Questions
Acousticabio's website is http://www.acoustica.bio
Acousticabio's LinkedIn profile is https://www.linkedin.com/company/acousticabio
Acousticabio has
15 employees.
View email and phone details for 15
employees at Acousticabio.
Acousticabio's industry is
Biotechnology
Acousticabio's top competitors are
Medtronic,
Kymera Therapeutics,
Sanofi,
Cellino,
Zepteon, Inc.,
Flagship Pioneering,
Generate:biomedicines,
Tessera Therapeutics,
Elektrofi,
Amgen.
Acousticabio's categories are Biotechnology
Acousticabio's founding year is 2021
